Results 111 to 120 of about 674,512 (170)

Novel biomarkers for prognosis in patients with localized prostate cancer. [PDF]

Oncol Lett
Goulielmaki M, Stokidis S, Anagnostou T, Gritzapis AD, Tsitsilonis OE, Baxevanis CN, Fortis SP.   +6 more
europepmc   +1 more source

The future of androgen receptor targeting in prostate cancer: third-generation inhibitors and beyond

Alice Bernard‐Tessier, Natacha Naoun, Solenn Barraud, Ronan Flippot, Cédric Pobel, Macarena Rey, Capucine Baldini, Christophe Massard, Anna Patrikidou, Alina Fuerea, Mario Di Palma, Laurence Albigès, Yohann Loriot, Karim Fizazi   +13 more
openalex   +1 more source

Paired normal-tumor exome sequencing in metastatic prostate cancer: interplay between germline and somatic data

Gabriel de Souza Macedo, Jaqueline Bohrer Schuch, Angélica Cerveira de Baumont, Giovana Dallaio Curzel, Cláudia Bordignon, Mahira Lopes Rosa, Nathan Araujo Cadore, Juliana Sena de Souza, Daniela Lacerda Costa Louzeiro, Lilian Arruda do Rêgo Barros, Alessandra Notari, Aline Bobato Lara Gongora, Vitor Fiorin de Vasconcellos, Williams Fernandes Barra, Henrique Guesser Ascenco, Daniel D’Almeida Preto, J. Menezes, Edilmar de Moura Santos, Gustavo Werutski, Pedro Emanuel Rubini Liedke, Glaucio Bertollo, Eduardo Kowalski Neto, André Luiz Campos Mancini, Marina Bessel, Daniela Dornelles Rosa   +24 more
openalex   +1 more source

Recognition of HSPB8 as a potential therapeutic target for prostate cancer. [PDF]

Front Genet
Fu X, Wang Y, Li H.
europepmc   +1 more source

Photoacoustic imaging in prostate cancer: a systematic review and meta-analysis

Muteb Alrashidi, Abdullah Almatrafi, Abdulrahman A. Almohammadi, Sourav Banerjee, Ghulam Nabi, James Joseph   +5 more
openalex   +1 more source

Increased expression of GCNT1 is associated with altered O-glycosylation of PSA, PAP, and MUC1 in human prostate cancers

, 2014
Zuxiong Chen, Zulfiqar Gulzar, Catherine A. St. Hill, Bruce Walcheck, James D. Brooks   +4 more
openalex   +1 more source

Construction and application of a humanized mouse model for prostate cancer in immunotherapy. [PDF]

Cancer Immunol Immunother
Guo W, Li H, Zhao Y, Qin J, Meng H, Ge X, Zhang C, Shi C.   +7 more
europepmc   +1 more source

Acute toxicities of moderately hypofractionated radiotherapy in the treatment of localised prostate cancer

Erik Roos, K Pillay, Sheynaz Bassa
openalex   +1 more source

Interprovider Variation in Initiation of Bone-Modifying Agents for Patients With Prostate Cancer. [PDF]

JCO Oncol Pract
Mitchell AP, Salner A, Palyca P, Farooki A, Persaud S, Chakraborty N, Bhamidipati D, Klimchuk M, Dinan MA, Leapman MS, Lipitz-Snyderman A, Hamid A, Ostroff JS, Morris MJ.   +13 more
europepmc   +1 more source

<p>miR-129-5p inhibits prostate cancer proliferation via targeting ETV1</p>

, 2019
Ge Gao, Dianhui Xiu, Bin Yang, Daju Sun, Xin Wei, Youpeng Ding, Yanan Ma, Zhixin Wang   +7 more
openalex   +2 more sources